Role of CD-38 in Multiple Myeloma Treatment: Market Forecast and Innovations
The role of CD-38 in multiple myeloma treatment is pivotal, and the CD-38 market is on a strong upward trajectory. With a promising pipeline, expanding patient populations, and cutting-edge combination therapies, the future of CD-38-targeted therapies looks bright for patients and healthca
